$1.920
-0.113 (-5.88%)收盤時
RBOT 獲利能力與利潤率
Evaluating the bottom line, Vicarious Surgical Inc maintains a gross margin of N/A. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at N/A, while the net margin is N/A. These profitability ratios, combined with a Return on Equity (ROE) of -148.93%, provide a clear picture of how effectively RBOT converts its operational activities into shareholder value.
RBOT 同業比較
In the context of the broader market, RBOT competes directly with industry leaders such as VVOS and ALUR. With a market capitalization of N/A, it holds a significant position in the sector. When comparing efficiency, RBOT's gross margin of N/A stands against VVOS's 47.41% and ALUR's 49.06%. Such benchmarking helps identify whether Vicarious Surgical Inc is trading at a premium or discount relative to its financial performance.
Vicarious Surgical Inc 財務表現
For Q3 2025, revenue remained at 0 with no growth. Net income dropped to -$11.058M, down -35.30% YoY. EPS declined to -1.86, down -35.86% YoY. Gross margin remained at 0, showing no improvement.
Financials
本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。